Ozempic consistently delivers nearly twice that
Unexplained gastrointestinal symptoms: think mitochondrial disease
Underpinning this expansion, the US gene therapy market is projected to reach $22.23 billion by 2034, with delivery technologies such as AAV vectors expected to show the highest growth through 2034
By Lauren Berryman May 21, 2025 03:30 PM CDT Featured Stories Providers How Risant-owned Cone Health plans to grow under new CEO Cone Health is a relatively small system in North Carolina, surrounded by heavyweights such as Advocate Health and UNC Health
2007: A study in 36 people (average age 63) with coronary artery disease found that taking 500 mg of acetyl-L-carnitine plus 200 mg of alpha-lipoic acid twice daily for 8 weeks lowered systolic blood pressure by 9 mmHg in those with coronary artery disease and high blood pressure, which was significant compared to placebo
These two conditions are closely interrelated, with DM representing a significant risk factor for CVD due to factors such as obesity, hypercholesterolemia, atherosclerosis, microcirculation disorders, and hypertension [1, 2]
